Identifying patients with resistant hypertension and options for clinical management (Q39515228)

12 September 2017

title

Identifying patients with resistant hypertension and options for clinical management (English)

1 reference

12 September 2017

main subject

arterial hypertension

0 references

author name string

Tommy Tsang Cheung

series ordinal

1

1 reference

12 September 2017

Bernard Man Yung Cheung

series ordinal

2

1 reference

12 September 2017

publication date

1 November 2012

1 reference

12 September 2017

1 reference

12 September 2017

volume

8

1 reference

12 September 2017

issue

6

1 reference

12 September 2017

page(s)

837-846

1 reference

What is the prevalence of resistant hypertension in the United States?

12 September 2017

cites work

1 reference

Incidence and prognosis of resistant hypertension in hypertensive patients

21 January 2018

1 reference

Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

21 January 2018

1 reference

Resistant hypertension revisited: a comparison of two university-based cohorts.

21 January 2018

1 reference

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk

21 January 2018

1 reference

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

21 January 2018

1 reference

Prevalence of Resistant Hypertension in the United States, 2003–2008

21 January 2018

1 reference

High prevalence of cardiac and extracardiac target organ damage in refractory hypertension.

21 January 2018

1 reference

Dietary sodium restriction as adjunctive treatment of hypertension

21 January 2018

1 reference

Alcohol intake and hypertension subtypes in Chinese men.

21 January 2018

1 reference

The effect of a losartan-based treatment regimen on isolated systolic hypertension

21 January 2018

1 reference

Hypertension associated with early stage kidney disease. Complementary roles of circulating renin, the body sodium/volume state and duration of hypertension

21 January 2018

1 reference

Sympathetic overactivity in patients with chronic renal failure

21 January 2018

1 reference

Abnormalities of endothelial function in patients with predialysis renal failure

21 January 2018

1 reference

Hypertension in renal parenchymal disease: why is it so resistant to treatment?

21 January 2018

1 reference

The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects.

21 January 2018

1 reference

Obstructive sleep apnea syndrome and hypertension: mechanism of the linkage and 24-h blood pressure control

21 January 2018

1 reference

Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis

21 January 2018

1 reference

Effects of celecoxib on ambulatory blood pressure in hypertensive patients on ACE inhibitors

21 January 2018

1 reference

Herbs and alternative therapies in the hypertension clinic

21 January 2018

1 reference

Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions.

21 January 2018

1 reference

Mechanisms and treatment of resistant hypertension

21 January 2018

1 reference

Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report

21 January 2018

1 reference

Endothelin-1 and endothelin receptor antagonists in cardiovascular remodeling

21 January 2018

1 reference

Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs

21 January 2018

1 reference

Darusentan: an effective endothelinA receptor antagonist for treatment of hypertension

21 January 2018

1 reference

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial

21 January 2018

1 reference

Implantable device therapy for the treatment of resistant hypertension

21 January 2018

1 reference

Prolonged activation of the baroreflex produces sustained hypotension.

21 January 2018

1 reference

Influence of prolonged baroreflex activation on arterial pressure in angiotensin hypertension.

21 January 2018

1 reference

Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial

21 January 2018

1 reference

Baroreflex Activation Therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial

21 January 2018

1 reference

Relationship between central sympathetic activity and stages of human hypertension

21 January 2018

1 reference

Renal sympathetic denervation and systemic hypertension.

21 January 2018

1 reference

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial

21 January 2018

1 reference

Renal Sympathetic Denervation Reduces Left Ventricular Hypertrophy and Improves Cardiac Function in Patients With Resistant Hypertension

21 January 2018

1 reference

Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension

21 January 2018

1 reference

Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea

21 January 2018

1 reference

Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled

21 January 2018

1 reference

Differential Control of Systolic and Diastolic Blood Pressure

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FCA.12.66

1 reference

12 September 2017

1 reference